--- title: "Selank: Dosing & Vendor Prices | BodyHackGuide" url: https://www.bodyhackguide.co/compound/selank description: "Selank: dosing protocols, mechanism & side effects, 88 PubMed results. Compare 5 current vendor prices." lang: en --- Skip to content Compare notes on r/BodyHackGuide (https://reddit.com/r/bodyhackguide) Compare notes with other researchers. Join r/BodyHackGuide (https://reddit.com/r/bodyhackguide) Image: Selank molecular structure (https://www.bodyhackguide.co/assets/peptide-structure-placeholder-DUmZBF_j.png) # Selank Nootropics (https://www.bodyhackguide.co/wiki#cat-nootropics)Approved (Russia, as anxiolytic and nootropic medication) Also known as: TP-7, Selank Spray Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro, 750 Da molecular weight) developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences as a synthetic analog of tuftsin — an immunomodulatory tetrapeptide (Thr-Lys-Pro-Arg) that is naturally cleaved from the Fc region of immunoglobulin G. The original tuftsin molecule has well-documented immunomodulatory and neurotropic effects but is rapidly degraded by peptidases in plasma, limiting its therapeutic utility. R Featured vendor $4.00/mg $39.99 for 10mg at ResearchChemHQ · Buy at RC: https://researchchemhq.co/product/selank-10mg/?ref=oyxnywoz Half-life: ~2-3 minutes plasma half-life (functional anxiolytic and noot… Route: Intranasal MW: 751.9 Da CAS: 129843-05-03 88 PubMed results (https://pubmed.ncbi.nlm.nih.gov/?term=selank%20peptide) Last reviewed: May 4, 2026 Reconstitution Calculator for Selank Pre-filled · 5mg vial · 250mcg dose https://www.bodyhackguide.co/tools/reconstitution/selank ## Overview ### At A Glance Mechanism Primary Mechanism: Multi-System Neurochemical Modulation… Half-Life ~2-3 minutes plasma half-life (functional anxiolytic and nootropic effects persist 12-24 hours due to gene expression and neurotransmitter modulation) Dosing Intranasal 1–3 times daily Dose Range 250-750 mcg intranasal daily (0.15% solution: 2-3 drops per nostril 2-3x daily); typical course is 14-21 days Routes Intranasal Common Vials 5mg 10mg Potential Benefits Anxiolytic effects comparable to benzodiazepines but without sedation or dependence in Russian clinical trials (PMID: 18454096) Positive allosteric modulation of brain GABA receptors through a non-benzodiazepine binding site (PMID: 30255741) Immunomodulation via Th1/Th2 cytokine balance and IL-6 regulation in patients with anxiety-asthenic disorders (PMID: 18577961) Cognitive and memory support linked to BDNF upregulation in the hippocampus in preclinical models (PMID: 18841804) Modulation of the endogenous enkephalin-opioid system supporting mood and stress tolerance (PMID: 22550852) Anti-inflammatory and adaptogenic effects through normalization of stress-induced cytokine dysregulation Non-addictive anxiolytic profile - no tolerance, withdrawal, or dependence reported across years of Russian clinical use Safety Notes Common Mild nasal irritation or tingling with intranasal administration Transient mild fatigue during first few days of use Slight metallic taste reported by some users Serious No serious adverse events reported in Russian post-marketing surveillance over 20+ years No evidence of physical dependence or withdrawal syndrome upon discontinuation Limited safety data from Western clinical trials — predominantly Russian research ### Mechanism of Action ### Primary Mechanism: Multi-System Neurochemical Modulation Selank does not have a single clean receptor-binding mechanism. Unlike benzodiazepines (GABA-A positive allosteric modulators), SSRIs (serotonin reuptake inhibition), or buspirone (5-HT1A partial agonism), Selank produces its anxiolytic and nootropic effects through coordinated modulation of multiple neurotransmitter systems. The most consistently documented mechanisms include: #### GABAergic Modulation Selank increases GABAergic tone in several brain regions, particularly the hypothalamus and limbic structures. Unlike benzodiazepines, this increase does NOT appear to be through direct GABA-A receptor binding. Instead, Selank appears to: - Increase GABA release from presynaptic terminals - Modulate GABA-A receptor subunit expression over time - Enhance GABAergic signaling indirectly through kinase cascades This GABAergic enhancement contributes to the anxiolytic effect but does so without producing the sedation, muscle relaxation, and cognitive dulling that benzodiazepines cause ([Kozlovskaya et al., 2003]). #### Serotonergic Effects Selank modulates serotonin metabolism, increasing brain serotonin turnover and affecting tryptophan uptake. Effects on specific 5-HT receptors are less well-characterized, but the compound appears to interact indirectly with serotonergic systems in a way that contributes to mood stabilization without the acute side effect burden of SSRIs ([Samotrueva et al., 2011]). #### Endogenous Opioid System Selank potentiates activity of endogenous opioid systems, particularly enkephalin-dependent pathways. This is thought to contribute to the mood-elevating effect and may explain the subjective sense of well-being that many users report. Unlike exogenous opioids, this potentiation does NOT produce dependence, tolerance, or respiratory depression. The effect appears to be modulation of enkephalinase enzymes (reducing enkephalin breakdown) rather than direct opioid receptor agonism. #### BDNF and Neurotrophic Effects Selank increases expression of brain-derived neurotrophic factor (BDNF), a key neurotrophin involved in synaptic plasticity, learning, memory, and adult neurogenesis. Elevated BDNF is a common downstream mechanism of antidepressants, exercise, and other pro-cognitive interventions. Selank's nootropic effects — improved concentration, memory, and cognitive endurance — are thought to partially derive from BDNF elevation over chronic dosing ([Inozemtseva et al., 2008]). #### Immunomodulatory Effects Selank inherits some immunomodulatory activity from its tuftsin parent. It affects cytokine expression, lymphocyte activation, and inflammatory markers in ways that may contribute to mood and cognitive effects through gut-brain axis and neuroinflammation pathways. This is less clinically relevant than the direct neuropharmacological effects but may contribute to long-term benefit. #### Gene Expression and Epigenetic Effects Emerging research suggests Selank modulates expression of genes involved in anxiety, depression, and memory circuits. The full scope of these effects is not well-characterized, but it contributes to the "long-tail" of clinical benefit that appears to outlast immediate plasma exposure. ### Absence of Classical Receptor Binding Extensive screening has not identified a single high-affinity receptor for Selank. Unlike most pharmacologically active peptides (oxytocin, vasopressin, opioids, angiotensin, etc.), Selank does not bind with high affinity to any known peptide receptor. This is unusual and has led researchers to propose that Selank: 1. Activates multiple lower-affinity sites in parallel 2. Modulates enzymatic activity (peptidases, kinases) rather than directly signaling through receptors 3. Affects membrane properties or intracellular signaling in non-classical ways 4. Binds to a receptor that remains uncharacterized Whatever the molecular explanation, the clinical pharmacology is the empirical fact: intranasal Selank 300 mcg produces measurable anxiolytic and nootropic effects in humans that show up on psychiatric rating scales and in EEG measurements. ### Pharmacokinetics Selank is administered intranasally as a 0.15% aqueous solution (1.5 mg/mL). Each 0.05 mL (50 mcL) spray delivers 75 mcg of Selank; a typical 2-spray dose (one spray per nostril) delivers approximately 150 mcg, and 4 sprays deliver 300 mcg. Key pharmacokinetic features: - **Rapid onset**: Effects begin within 15-30 minutes of intranasal administration - **Peak effect**: 30-60 minutes after dosing - **Duration of effect**: 4-8 hours per dose, though some effects outlast plasma exposure - **Plasma half-life**: Short — the intact peptide is cleared from blood within 1-2 hours - **Bioavailability**: Substantially higher via intranasal than oral route due to bypass of GI peptidases - **CNS penetration**: Intranasal delivery provides direct access via olfactory and trigeminal nerve pathways, bypassing the blood-brain barrier - **Metabolism**: Enzymatic cleavage to smaller peptide fragments; some fragments may retain activity - **Accumulation**: Does not accumulate with chronic dosing ### Intranasal vs. Other Routes **Intranasal (standard)**: Optimal for CNS-targeted effects. Direct nose-to-brain delivery via olfactory pathway is the primary reason intranasal works well for neuropeptides. **Subcutaneous injection**: Used in some research protocols and by some biohackers. May produce somewhat different profile emphasizing peripheral effects (immunomodulation, HPA axis). Not commonly used for anxiolytic indication. **Intramuscular injection**: Used in research; not practical for home use. **Oral**: Essentially ineffective due to GI peptidase degradation of peptide. **Sublingual**: Limited data; may provide partial absorption but less characterized than intranasal. ### Chronic Dosing Effects Chronic Selank administration (weeks to months) appears to produce progressive benefits beyond acute effects: - BDNF elevation that accumulates over weeks - Gene expression changes affecting anxiety-related pathways - Potential "trait" anxiolysis with diminishing acute effect over time but maintained baseline benefit - No evidence of tachyphylaxis at therapeutic doses This chronic effect pattern means Selank's full clinical value may only emerge over 4-8+ weeks of regular use, similar to SSRIs but without the initial activation/sedation side effects. ### Overview Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro, 750 Da molecular weight) developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences as a synthetic analog of tuftsin — an immunomodulatory tetrapeptide (Thr-Lys-Pro-Arg) that is naturally cleaved from the Fc region of immunoglobulin G. The original tuftsin molecule has well-documented immunomodulatory and neurotropic effects but is rapidly degraded by peptidases in plasma, limiting its therapeutic utility. Selank adds a Pro-Gly-Pro tail to the tuftsin sequence, which confers resistance to enzymatic degradation while preserving pharmacological activity. In Russia, Selank has been approved since 2004 for the treatment of generalized anxiety disorder (GAD) and is available by prescription at pharmacies across the Russian Federation and several neighboring countries. It is marketed as a 0.15% intranasal solution under the brand name "Selank" (╨í╨╡╨╗╨░╨╜╨║) by Peptogen, a Moscow-based pharmaceutical company. In Western markets, Selank has never been submitted for FDA, EMA, or other major regulatory approval — not because of unfavorable data, but because the commercial pharmaceutical industry has no mechanism to profit from a peptide with an expired patent and no Western development sponsor. As a result, Selank circulates in the biohacking and peptide-curious community primarily as a "research chemical" through specialty peptide suppliers, where it is sold in intranasal spray or injectable formulations. The pharmacological profile of Selank is distinctive among anxiolytics. Unlike benzodiazepines, it does NOT cause sedation, cognitive dulling, tolerance, dependence, or withdrawal. Unlike SSRIs, it has rapid onset (within 30-60 minutes of intranasal administration) and effects that outlast plasma presence. Unlike buspirone, it does not require weeks of chronic dosing to manifest effects. The compound appears to work through modulation of multiple neurotransmitter systems simultaneously — GABAergic, serotonergic, dopaminergic, and endogenous opioid — producing what the Russian clinical literature describes as an "anxiolytic + nootropic" profile: the user feels calmer but also more mentally engaged, not sedated. This unusual combination has driven substantial interest in Western biohacking circles as an alternative or adjunct to conventional anxiety pharmacology. Selank has been studied in Russian clinical populations for over two decades with a consistent efficacy and safety pattern across roughly 30-50 published clinical papers. The evidence base is real but has important limitations: most trials are Russian-language, published in Russian journals, with small sample sizes (often 30-100 patients), and use Russian psychiatric rating scales rather than the validated Western instruments (GAD-7, HAM-A, Beck Anxiety Inventory) that would facilitate cross-validation. Western meta-analyses and systematic reviews are essentially nonexistent. The Russian regulatory approval is real and meaningful — Russian drug regulation, while different from FDA standards, does require efficacy and safety evidence — but it does not automatically translate to confidence in Western evidence-based medicine frameworks. For the biohacking community, Selank's appeal is the combination of (1) rapid-acting anxiolysis without sedation, (2) cognitive enhancement rather than dulling, (3) favorable safety profile across decades of Russian use, (4) non-addictive, non-dependence-producing pharmacology, and (5) intranasal delivery that is simple and needle-free. Its limitations are (1) thin Western evidence base, (2) variable quality from research chemical suppliers, (3) lack of FDA regulation or oversight, (4) modest effect magnitude in some users relative to expectations, and (5) cost relative to generic anxiety pharmacology. This entry covers the pharmacology, clinical evidence, practical use considerations, and honest framing of the evidence gaps. Cross-reference with Semax (https://www.bodyhackguide.co/compound/semax), DSIP (https://www.bodyhackguide.co/compound/dsip), and Epithalon (https://www.bodyhackguide.co/compound/epithalon) for a complete picture of the Russian research peptide landscape. ## Chemical Information IUPAC Name Thr-Lys-Pro-Arg-Pro-Gly-Pro CAS Number 129843-05-03 Molecular Formula C33H57N11O9 Molecular Mass 751.87 g/mol Image: Selank molecular structure (https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/16129891/PNG) View on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/16129891 Amino Acid Sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP) - a synthetic heptapeptide; the tuftsin fragment Thr-Lys-Pro-Arg (TKPR) extended at the C-terminus with Pro-Gly-Pro (PGP) to confer resistance to enzymatic degradation. Molecular formula C33H57N11O9. ## Dosing & Protocols ### Unlock the dosing protocols Enter your email to keep reading. It is free, and it opens these tabs on every compound page in this browser. - Dose, route, how often and how long - Beginner, intermediate and advanced protocols - Reconstitution and handling notes - Stacking notes You also get the free peptide cheat sheet by email. Unsubscribe anytime. Have an account? Sign in (https://www.bodyhackguide.co/auth) ## Research ### Unlock the research summary - A summary of the key research - Safety and side effects - A link to the PubMed results ## Interactions ### Interaction Matrix ### Contraindications ### Absolute Contraindications Selank should NOT be used in the following circumstances: - **Known allergy or hypersensitivity to Selank or components** - **Pregnancy**: Insufficient safety data; peptide effects on developing nervous system not characterized - **Lactation**: Insufficient safety data - **Active psychosis or severe psychiatric emergencies**: Requires specialist management with established medications - **Severe untreated medical conditions potentially manifesting as anxiety**: Thyrotoxicosis, pheochromocytoma, arrhythmia — treat the underlying condition ### Relative Contraindications / Caution Warranted - **Pediatric use**: Limited data; some Russian clinical use in children but Western practice would be to avoid - **Moderate to severe liver disease**: Peptide clearance generally preserved but data in severe hepatic impairment is limited - **Moderate to severe kidney disease**: Same consideration - **Active substance use disorder**: Selank itself not addictive, but complete treatment approach needed - **Severe anxiety requiring urgent care**: Selank is adjunctive; severe panic or suicidal anxiety need professional evaluation - **Nasal pathology**: Chronic rhinitis, deviated septum, nasal polyps may impair absorption; consider injection route or treat nasal condition ### Psychiatric Considerations - **Active suicidal ideation**: Professional psychiatric care is primary; Selank is not sufficient alone - **Severe depression**: Selank has modest mood effect; not a substitute for antidepressants in major depression - **PTSD**: Selank may be useful adjunct but complete trauma-focused care (therapy, sometimes medication) is primary - **Bipolar disorder**: Manic or hypomanic episodes require specific management; Selank has no established role in mood stabilization - **Panic disorder**: May help but often insufficient; complete CBT ± SSRI is first-line - **OCD**: Modest effect possible but high-dose SSRI is first-line ### Drug Interactions Formal interaction studies are limited. Based on pharmacology: - **SSRIs/SNRIs**: No known dangerous interaction; combination sometimes useful; theoretical serotonin syndrome concern with very high doses of either - **MAOIs**: Theoretical concern due to serotonergic component; prudent to avoid - **Tricyclic antidepressants**: No significant interaction expected - **Benzodiazepines**: Combined often useful, no dangerous interaction; additive anxiolysis (desired) - **Buspirone**: Compatible combination - **Opioids**: Theoretical interaction via opioid system modulation; clinically non-problematic in limited reports - **Alcohol**: No dangerous interaction; but alcohol disrupts anxiety management - **Stimulants**: No dangerous interaction; may counter stimulant anxiety - **Antipsychotics**: No specific interactions noted - **Lithium**: No known interaction - **Anticonvulsants**: No known interaction - **Other research peptides** (Semax, DSIP, etc.): Commonly stacked without reported issues ### Medical Conditions Requiring Caution - **Cardiovascular disease**: No specific CV effects noted, but any new medication in unstable CV disease requires consideration - **Endocrine disorders**: Thyroid dysfunction should be treated — anxiety may have endocrine cause - **Chronic respiratory disease**: Peptide itself is respiration-neutral; nasal delivery may irritate in severe rhinitis/sinusitis - **Migraine disorders**: No specific interaction; nasal spray may worsen migraine in some sensitive users - **Seizure disorders**: No known effect on seizure threshold; baseline caution with any neuroactive compound - **Immunocompromised states**: Selank's immunomodulatory effects are mild but discuss with treating physician ### Contraindicated Combinations While Selank is generally safe in combination, these combinations warrant specific caution: - **MAOIs + Selank**: Theoretical serotonin syndrome risk; avoid - **Multiple serotonergic agents at high doses**: SSRI + SNRI + Selank + 5-HTP + St. John's wort — serotonin toxicity risk - **Multiple sedatives**: Selank + benzodiazepine + alcohol + opioid — additive CNS effects - **Complex polypharmacy without physician oversight**: Unpredictable interactions ### Physical Examination and Workup Before Starting For anxiety that has not been medically evaluated: 1. **TSH and free T4**: Hyperthyroidism presents as anxiety 2. **Caffeine intake assessment**: Common overlooked cause 3. **Substance use history**: Cannabis, stimulants, alcohol — treat underlying issue 4. **Sleep evaluation**: Poor sleep causes anxiety 5. **Cardiac evaluation if palpitations/chest symptoms**: EKG, consider Holter 6. **B12, folate, vitamin D**: Deficiencies can manifest as mood/anxiety symptoms 7. **Blood glucose, HbA1c**: Dysglycemia affects mood 8. **Testosterone if male**: Low T associated with anxiety in some men 9. **Menopausal status if female**: Perimenopausal anxiety common 10. **Medication review**: Current medications that could contribute to anxiety ### Safety Monitoring Selank itself doesn't require specific lab monitoring. General wellness monitoring is reasonable as part of broader health maintenance. Symptoms warranting discontinuation or medical evaluation: - Severe or unusual headache - Any allergic-type reaction - Unexpected mood changes (severe depression, mania, psychosis) - Worsening rather than improving anxiety - Physical symptoms suggesting systemic reaction ### Pregnancy and Fertility No data in pregnancy or lactation. Avoid. Effects on fertility: Not documented in either direction. For couples trying to conceive: prudent to avoid the female partner's use; male use less concerning but data absent. ### Pediatric Use Some Russian clinical use in children with anxiety exists, but: - Western practice would typically avoid in minors - Non-pharmacological interventions (therapy, environmental modification, behavioral support) should be primary - If medication indicated, established pediatric psychiatric care with approved agents is preferred ### Elderly Considerations Standard doses typically appropriate: - Start at 150 mcg to assess tolerability - Monitor for mild fatigue (uncommon but possible) - No specific dose reduction required - Favorable cognitive profile compared to benzodiazepines (which are discouraged in elderly) - Useful option in elderly where BZDs are problematic ### Driving and Machinery Selank does NOT impair driving, coordination, or reaction time at therapeutic doses in the vast majority of users. Assess individual response before safety-critical activities. Most users experience no impairment at any dose. ### Occupational Considerations - Not on current WADA prohibited list (verify before competition) - Not routinely tested in workplace drug screening - Not scheduled/controlled in most jurisdictions (exception: Russia treats as prescription) - Safety-critical professions (pilots, surgeons, operators): verify individual tolerance ### Long-Term Use Philosophy While Selank appears safe for long-term use based on Russian clinical experience (15+ years of approval), the spirit of good pharmacology is to: - Use the minimum dose that achieves the goal - Periodic breaks rather than continuous use - Combine with non-pharmacological approaches (therapy, lifestyle) - Regularly reassess ongoing need - Avoid drift toward polypharmacy without clear rationale Indefinite nightly use of any anxiolytic, even a safe one, reflects either (1) untreated underlying condition, (2) lifestyle factors not addressed, or (3) psychological dependence that may benefit from reassessment. The goal is flexibility and function, not permanent pharmacology. Research Disclaimer This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds. Best Price $25.00 up to $89.99 Best $/mg $3.4650 Vendors 5 Listings 6 vial, nasal Dosage Form Sort | Vendor | Product | Form | Qty | Price | $/mg | Coupon | | | --- | --- | --- | --- | --- | --- | --- | --- | | Image: ResearchChemHQ logo (https://staging.researchchemhq.co/wp/wp-content/uploads/2024/08/cropped-RCHQ-Invert-Logo-e1724477505900.png) ResearchChemHQ (https://www.bodyhackguide.co/vendors/researchchemhq) 100: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US | Selank 10mg | vial | 1 vial ● In Stock | $39.99 | $4.00 | REDDIT | Buy: https://researchchemhq.co/product/selank-10mg/?ref=oyxnywoz | | Image: BHG Labs logo (https://bhglabs.co/store/wp-content/uploads/2026/06/logo-full.png) BHG Labs (https://www.bodyhackguide.co/vendors/bhg-labs) 70: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US | Selank 10mg Research Atomizer | nasal | 1 bottle ● In Stock | $89.99 | — | BHG20 | Buy: https://bhglabs.co/product/selank/?ref=zmgqyxku&coupon=BHG20 | | Image: Optimum Formula logo (https://optimumformula.co/wp-content/uploads/2025/07/LOGO-OPTIMUM-NEW.png) Optimum Formula (https://www.bodyhackguide.co/vendors/optimum-formula) 100: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US | Selank 10mg | vial | 1 vial ● In Stock | $39.99 | $4.00 | REDDIT | Buy: https://optimumformula.co/product/selank/?ref=ruyhjwqh | | Image: Ion Peptide logo (https://ionpeptide.com/wp-content/uploads/2025/08/ion-peptide-logo-1-300x148.jpg) Ion Peptide (https://www.bodyhackguide.co/vendors/ion-peptide) 70: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US 🌍 International | Selank 5mg | vial | 1 vial ● In Stock | $25.00 BEST | $5.00 | — | Buy: https://ionpeptide.com/product/selank-2/?ref=reddit15 | | Image: Ion Peptide logo (https://ionpeptide.com/wp-content/uploads/2025/08/ion-peptide-logo-1-300x148.jpg) Ion Peptide (https://www.bodyhackguide.co/vendors/ion-peptide) 70: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US 🌍 International | Selank 10mg | vial | 1 vial ● In Stock | $34.65 VALUE | $3.46 | — | Buy: https://ionpeptide.com/product/selank-2/?ref=reddit15 | | Image: VANDL Labs logo (https://halfnattys.shop/wp-content/themes/halfnattys/assets/img/logo.webp) VANDL Labs (https://www.bodyhackguide.co/vendors/vandl-labs) 50: https://www.bodyhackguide.co/vendor-trust-scorecard 🇺🇸 US | Selank Nasal Spray 15mL | nasal | 15mL bottle ● In Stock | $44.99 | — | CHON | Buy: https://www.vandl-labs.com/product/selank-2/?ref=choncho | ### Sign in to leave a review Reviews on BodyHackGuide are tied to verified user accounts and moderated before publishing. Sign in (free, no spam) to share your experience with Selank. Current low $25.00 current listings 7-day low — not enough history yet 30-day low — not enough history yet 30-day change — not enough history yet Tracking since Mar 13, 2026 · 6 data points ## Price History 5 data points ### Vendors Selling Selank #### Ion Peptide 4.5 2 listings · from $25.00 https://www.bodyhackguide.co/vendors/ion-peptide #### Optimum Formula 4.9 1 listing · from $39.99 https://www.bodyhackguide.co/vendors/optimum-formula #### ResearchChemHQ 4.7 1 listing · from $39.99 https://www.bodyhackguide.co/vendors/researchchemhq #### VANDL Labs 1 listing · from $44.99 https://www.bodyhackguide.co/vendors/vandl-labs #### BHG Labs 4.8 1 listing · from $89.99 https://www.bodyhackguide.co/vendors/bhg-labs How we score these vendors Every supplier above is graded 0 to 100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank. View Scorecard (https://www.bodyhackguide.co/vendors/scorecard) ### Related Compounds View All (https://www.bodyhackguide.co/wiki) ### 9-Me-BC (9-Methyl-β-carboline) Nootropics Preclinical 9-Methyl--carboline (9-Me-BC) is a synthetic -carboline alkaloid that has drawn nootropic-community interest for a preclinical property that is genuinely unusual among -carbolines: in rodent and cell-culture studies it appears to stimulate the dopaminergic phenotype - raising tyrosine hydroxylase, the number of differentiated dopamine neurons and dopamine content - while also showing neuroprotective, neurorestorative and anti-inflammatory effects, plus in-vitro MAO-A/MAO-B inhibition [PMID:17913302, PMID:20374418, PMID:32285253]. t½ Not characterized in humans (no pharmacokinetic data). Community/anecdotal only: ~5-25 mg per day, oral. No validated or approved human dose exists. 6 PubMed View Profile https://www.bodyhackguide.co/compound/9-mbc ### Aniracetam Nootropics Approved (Italy) Aniracetam is a pyrrolidinone in the racetam family, developed by Hoffmann-La Roche under the code Ro 13-5057. t½ About half an hour for the parent drug in humans. Plasma elimination half-life was 0.47 to 0.49 hours after a single 400 mg oral dose in 20 healthy male volunteers (PMID: 19025058). Aniracetam is extensively metabolized to N-anisoyl-GABA and anisic acid; in six elderly hospitalized patients with cerebrovascular disease and reduced creatinine clearance, metabolite half-life was 4 to 7 times longer than in young volunteers (PMID: 9062694). Preclinical View Profile https://www.bodyhackguide.co/compound/aniracetam ### Bemethyl (bemitil) Nootropics Approved (Russia) Bemethyl, known in the Russian literature as bemitil and sold in the region under names including Metaprot, Bemactor and Antihot, is 2-ethylthiobenzimidazole, normally handled as the hydrobromide salt. t½ Not established in humans; in healthy volunteers given a single 250 mg oral dose of the Metaprot capsule form, peak serum ethylthiobenzimidazole averaged 0.91 microg/mL at about 1.06 h, and no terminal half-life was reported (PMID: 21870773) Preclinical View Profile https://www.bodyhackguide.co/compound/bemethyl ### Bromantane Nootropics Russia Approved Bromantane is an atypical psychostimulant and anxiolytic developed in the 1980s at the Zakusov Institute of Pharmacology of the Russian Academy of Medical Sciences, originally created as an adaptogen for Soviet military and elite athletic use and later approved in Russia for the treatment of neurasthenic and asthenic disorders under the trade name Ladasten. 34 PubMed View Profile https://www.bodyhackguide.co/compound/bromantane ### Cyclazodone Nootropics Preclinical Cyclazodone is the N-cyclopropyl derivative of pemoline, a 4-oxazolidinone stimulant. Preclinical View Profile https://www.bodyhackguide.co/compound/cyclazodone ### Dihexa Nootropics Preclinical Dihexa is a synthetic peptide analogue of the angiotensin IV metabolite LVV-hemorphin-7, developed at Washington State University. t½ Not characterized in humans. Dihexa was engineered for metabolic stability (resistant to plasma and enzymatic degradation) and blood-brain-barrier penetration; in preclinical work its central procognitive effects appear to outlast its plasma presence. 5 to 40 mg oral per day (anecdotal range; no established human dose) 1 PubMed View Profile https://www.bodyhackguide.co/compound/dihexa ### Side-by-Side Comparisons All Comparisons (https://www.bodyhackguide.co/compare) Selank vs Semax: https://www.bodyhackguide.co/compare/selank-vs-semax Selank vs Phenibut: https://www.bodyhackguide.co/compare/selank-vs-phenibut View Full Dosage Guide → Protocols, calculator & safety for Selank https://www.bodyhackguide.co/guides/dosage/selank ### Related Articles All Posts (https://www.bodyhackguide.co/blog) #### Bacteriostatic Water vs a Finished Nasal Spray Base Most research nasal sprays are a peptide mixed into bacteriostatic water. A finished spray base is a different product: a carrier built for the nose, a chitosan-based mucosal hold, filtration before pack-out, and a metered sprayer. Here is what separates the two, and what neither one proves. 9/22/2026 https://www.bodyhackguide.co/blog/bacteriostatic-water-vs-finished-nasal-spray-base #### The 8 Best Peptide Companies for Research: 2026 Purity & Price Comparison A data-driven comparison of every active peptide vendor we track: COA audit results, price-per-mg tables for 19 compounds, and a step-by-step purchase guide. 9/16/2026 https://www.bodyhackguide.co/blog/best-peptide-companies-2026 #### Cognitive Enhancers by Mechanism and Safety: A Reference Guide A mechanism-first reference that groups cognitive enhancers into seven pharmacological classes and compares each on how it works and its main safety consideration, with a master table and honest evidence labels. Not a ranking, and not medical advice. 7/1/2026 https://www.bodyhackguide.co/blog/cognitive-enhancers-by-mechanism-and-safety ### Featured Price ⚗️ ResearchChemHQ $39.99($4.00/mg) 5 vendors · 6 listings ### Research Score 54 88 PubMed results ### Quality Indicators Data Completeness 100% Description Mechanism of Action Chemical Data Dosing Protocols Safety Profile PubMed Results Interactions Vendor Listings COA Verification 10 Verified COAs 2 Vendors w/ COA High verification rate (83%) Latest test: 3/1/2026 Research Volume 88 PubMed results Well-researched compound ### Quick Facts Half-Life Molecular Weight 751.87 g/mol Administration Intranasal CAS Number 129843-05-03 Trial Phase Approved (Russia, as anxiolytic and nootropic medication) ### Safety Profile Common Side Effects - • Mild nasal irritation or tingling with intranasal administration - • Transient mild fatigue during first few days of use - • Slight metallic taste reported by some users Research Disclaimer This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use. ## Frequently Asked Questions What is Selank and where is it from? Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It's a stabilized synthetic analog of tuftsin, a naturally-occurring immunomodulatory peptide. Selank has been approved as a prescription anxiolytic in Russia since the 2000s under the brand name Selank, manufactured by Peptogen. In Western markets, it is sold as a 'research chemical' through peptide suppliers because no Western pharmaceutical company has pursued FDA approval. Is Selank approved by the FDA? No. Selank is approved by the Russian Federation state drug regulatory agency (Roszdravnadzor) for generalized anxiety disorder, but has never been submitted for FDA approval. This is primarily a commercial decision - the molecule is off-patent and no Western company has sufficient financial incentive to pursue development. The evidence base exists in Russian clinical literature but not in the large Western-standard trials that FDA requires. Selank circulates in the US exclusively through research peptide suppliers. How does Selank compare to benzodiazepines? Selank produces anxiolytic effects comparable to benzodiazepines in Russian comparative trials (Zozulya et al., 2008 (https://pubmed.ncbi.nlm.nih.gov/18454096/)) but with a dramatically different profile: NO sedation, NO cognitive impairment, NO dependence, NO tolerance, NO withdrawal. Selank users maintain or improve cognitive performance while anxious symptoms reduce. Benzodiazepines cause sedation, memory problems, and create dependence within weeks to months. For mild-to-moderate chronic anxiety, Selank's profile is clearly favorable; for severe acute anxiety or panic, benzodiazepines' rapid and strong effect may still be preferred. How should I dose Selank for anxiety? Standard starting dose is 150 mcg (1 spray each nostril) morning for first week, then increase to 300 mcg (2 sprays each nostril) morning. For ongoing anxiety, consider adding afternoon dose of 150-300 mcg. Total daily dose typically 300-600 mcg; Russian therapeutic protocols use up to 900 mcg daily divided into 2-3 doses. For acute situational anxiety (public speaking, medical appointments), 150-300 mcg 30-60 minutes before the event. Take 2-4 week courses with 1-2 week breaks. This is research/educational information, not medical advice. How quickly does Selank work? Acute anxiolytic effects begin within 15-30 minutes of intranasal administration, peak at 30-60 minutes, and last 4-8 hours per dose. Chronic effects (BDNF elevation, gene expression changes) accumulate over weeks of regular use, producing sustained 'trait' improvements in anxiety baseline over 2-8 weeks. This fast-onset + chronic-accumulation profile distinguishes Selank from SSRIs (slow onset, purely chronic) and benzodiazepines (fast onset, purely acute). Can Selank be used with antidepressants? Formal interaction data are limited, but Selank has no documented dangerous interaction with SSRIs (sertraline, escitalopram, fluoxetine, etc.) or SNRIs (venlafaxine, duloxetine), and it is commonly combined in Russian practice. It may be useful as a rapid-acting adjunct during the 2-4 week SSRI onset period or for residual anxiety on stable SSRI therapy. A theoretical serotonin-syndrome concern exists only at very high combined doses; at standard dosing this is not a clinical issue. Consult your prescribing clinician, especially if taking multiple psychiatric medications. What are Selank's side effects? Selank has one of the best safety profiles in the anxiolytic space. Common: mild nasal irritation (10-15%), mild headache (5-10%), altered taste during administration. Uncommon: dizziness, mild fatigue, nausea. NOT reported: dependence, tolerance, withdrawal, cognitive impairment, sexual dysfunction, weight gain, emotional blunting. Over years of Russian clinical use, no serious adverse events have been reported at therapeutic doses. This favorable profile is one of the main reasons for Selank's popularity in biohacking communities, though rigorous Western safety data are lacking. Is Selank addictive? No. Selank has NO documented addiction liability. Russian pharmacovigilance over many years of clinical use has not identified dependence, tolerance, withdrawal syndromes, or abuse patterns. This fundamentally distinguishes Selank from benzodiazepines, opioids, alcohol, and other anxiolytics that produce dependence. Selank can be stopped abruptly without medical supervision and restarted as needed without dose escalation. This profile makes it particularly appealing to users concerned about dependence with conventional anxiolytics. Does Selank work for cognitive enhancement? Yes, modestly. Selank produces cognitive improvements beyond what anxiolysis alone explains (Medvedev et al., 2014 (https://pubmed.ncbi.nlm.nih.gov/25176261/)), reported as mild nootropic effects on attention and memory. The mechanism appears to involve BDNF elevation, gene expression effects, and multi-neurotransmitter modulation. However, cognitive effects are modest - not dramatic. Selank is better characterized as 'cognition-preserving + mild enhancement' than a strong nootropic. For stronger cognitive effects, it's often stacked with Semax (https://www.bodyhackguide.co/compound/semax), which has more direct nootropic activity. What's the difference between Selank and Semax? Both are Russian intranasal peptides with overlapping but distinct profiles. Semax (https://www.bodyhackguide.co/compound/semax) is primarily a nootropic (cognition, focus, alertness) derived from ACTH, acting strongly on BDNF, dopamine, and neurotrophic systems. Selank is primarily anxiolytic (calm, stress tolerance) derived from tuftsin, acting on GABA, serotonin, and opioid systems. Semax makes you more alert and focused; Selank makes you calmer without sedation. Combined, they produce 'calm focus' and are frequently stacked: Semax morning for cognitive activation, Selank PRN or standing for anxiety management. Both have similar safety profiles and Russian regulatory approval. ## Research Tools ### Peptide Calculator Reconstitution & syringe units https://www.bodyhackguide.co/tools/reconstitution ### Reconstitution Guide How to mix, step by step https://www.bodyhackguide.co/guides/how-to-reconstitute-peptides ### Nasal Spray Calc mL per actuation https://www.bodyhackguide.co/tools/intranasal ### Half-Life Visualizer Decay curves https://www.bodyhackguide.co/tools/halflife ## Related Compounds ### 9-Me-BC (9-Methyl-β-carboline) Nootropics Preclinical ### Aniracetam Nootropics Approved (Italy) ### Bemethyl (bemitil) Nootropics Approved (Russia) ### Bromantane Nootropics Russia Approved ### Cyclazodone Nootropics Preclinical ### Dihexa Nootropics Preclinical ## Side-by-Side Comparisons Compare Selank head-to-head: mechanism, half-life, dosing, safety, and vendor prices. ## Research Benches Reference pages that put Selank next to the compounds people pair it with: roles, evidence, overlap and conflicts. No dosing. Research use only. Nasal Peptide Bench Selank and Semax, plus Adamax, the analogue with no data of its own research bench · no dosing https://www.bodyhackguide.co/stack/nasal-peptide-bench Free 2026 Peptide Cheat Sheet (PDF) 38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers. Download Free (https://www.bodyhackguide.co/guides/peptide-cheat-sheet-download) ### Need bloodwork before starting? Full hormone + metabolic panels from Anabolic Insights. Code CHONCH for first-order discount. Image: BodyHackGuide (https://www.bodyhackguide.co/assets/bodyhackguide-logo-DOzZNUyh.webp) ### BodyHackGuide Your biohacking research hub: compound pricing, brain health protocols, dosing tools, and vendor reviews. support@bodyhackguide.co Join our Discord: https://discord.gg/Mhq5UdRYBA r/BodyHackGuide on Reddit: https://reddit.com/r/BodyHackGuide #### Explore - Compare prices: https://www.bodyhackguide.co/compare - Vendors: https://www.bodyhackguide.co/vendors - Deals: https://www.bodyhackguide.co/deals - Coupons: https://www.bodyhackguide.co/coupons - Nootropics: https://www.bodyhackguide.co/nootropics - Brain health: https://www.bodyhackguide.co/brain-health - Blog: https://www.bodyhackguide.co/blog - Guides: https://www.bodyhackguide.co/guides #### Tools - Reconstitution: https://www.bodyhackguide.co/tools/reconstitution - Half-life visualizer: https://www.bodyhackguide.co/tools/halflife - COA reader: https://www.bodyhackguide.co/tools/coa - Cost calculator: https://www.bodyhackguide.co/tools/cost-calculator - Stack builder: https://www.bodyhackguide.co/stack-builder - All tools: https://www.bodyhackguide.co/tools #### Trust & vendors - Vendor directory: https://www.bodyhackguide.co/vendors - Trust scorecard: https://www.bodyhackguide.co/vendors/scorecard - Vendor trust badge: https://www.bodyhackguide.co/vendors/get-vetted - Scoring methodology: https://www.bodyhackguide.co/vendors/methodology - Peptide cheat sheet: https://www.bodyhackguide.co/guides/peptide-cheat-sheet-download #### Company - About: https://www.bodyhackguide.co/about - Affiliate disclosure: https://www.bodyhackguide.co/affiliate-disclosure - Editorial standards: https://www.bodyhackguide.co/editorial-standards - Creators: https://www.bodyhackguide.co/creators - Coaches: https://www.bodyhackguide.co/coaches - 1-on-1 coaching: https://www.bodyhackguide.co/coaching - Privacy: https://www.bodyhackguide.co/privacy - Terms: https://www.bodyhackguide.co/terms - Full site directory: https://www.bodyhackguide.co/site-directory **Affiliate Disclosure:** We rank every vendor on the same public, reproducible methodology (https://www.bodyhackguide.co/vendors/methodology), and we earn a commission from purchases made through some of our links at no extra cost to you. Full details in our affiliate disclosure (https://www.bodyhackguide.co/affiliate-disclosure). **Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell or ship any products. Always consult a qualified healthcare professional and comply with local regulations. © 2026 BodyHackGuide. All rights reserved. · Terms (https://www.bodyhackguide.co/terms) · Privacy (https://www.bodyhackguide.co/privacy) ## Structured data ```json [ { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co/" }, { "@type": "ListItem", "position": 2, "name": "Compounds", "item": "https://www.bodyhackguide.co/compare" }, { "@type": "ListItem", "position": 3, "name": "Selank" } ] }, { "@context": "https://schema.org", "@type": "Product", "name": "Selank", "description": "Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro, 750 Da molecular weight) developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences as a synthetic analog of tuftsin — an immunomodulatory tetrapeptide (Thr-Lys-Pro-Arg) that is naturally cleaved from the Fc region of immunoglobulin G. The original tuftsin molecule has well-documented immunomodulatory and neurotropic effects but is rapidly degraded by peptidases in plasma, limiting its therapeutic utility. Selank adds a Pro-Gly-Pro tail to the tuftsin sequence, which confers resistance to enzymatic degradation while preserving pharmacological activity. In Russia, Selank has been approved since 2004 for the treatment of generalized anxiety disorder (GAD) and is available by prescription at pharmacies across the Russian Federation and several neighboring countries. It is marketed as a 0.15% intranasal solution under the brand name \"Selank\" (╨í╨╡╨╗╨░╨╜╨║) by Peptogen, a Moscow-based pharmaceutical company. In Western markets, Selank has never been submitted for FDA, EMA, or other major regulatory approval — not because of unfavorable data, but because the commercial pharmaceutical industry has no mechanism to profit from a peptide with an expired patent and no Western development sponsor. As a result, Selank circulates in the biohacking and peptide-curious community primarily as a \"research chemical\" through specialty peptide suppliers, where it is sold in intranasal spray or injectable formulations. The pharmacological profile of Selank is distinctive among anxiolytics. Unlike benzodiazepines, it does NOT cause sedation, cognitive dulling, tolerance, dependence, or withdrawal. Unlike SSRIs, it has rapid onset (within 30-60 minutes of intranasal administration) and effects that outlast plasma presence. Unlike buspirone, it does not require weeks of chronic dosing to manifest effects. The compound appears to work through modulation of multiple neurotransmitter systems simultaneously — GABAergic, serotonergic, dopaminergic, and endogenous opioid — producing what the Russian clinical literature describes as an \"anxiolytic + nootropic\" profile: the user feels calmer but also more mentally engaged, not sedated. This unusual combination has driven substantial interest in Western biohacking circles as an alternative or adjunct to conventional anxiety pharmacology. Selank has been studied in Russian clinical populations for over two decades with a consistent efficacy and safety pattern across roughly 30-50 published clinical papers. The evidence base is real but has important limitations: most trials are Russian-language, published in Russian journals, with small sample sizes (often 30-100 patients), and use Russian psychiatric rating scales rather than the validated Western instruments (GAD-7, HAM-A, Beck Anxiety Inventory) that would facilitate cross-validation. Western meta-analyses and systematic reviews are essentially nonexistent. The Russian regulatory approval is real and meaningful — Russian drug regulation, while different from FDA standards, does require efficacy and safety evidence — but it does not automatically translate to confidence in Western evidence-based medicine frameworks. For the biohacking community, Selank's appeal is the combination of (1) rapid-acting anxiolysis without sedation, (2) cognitive enhancement rather than dulling, (3) favorable safety profile across decades of Russian use, (4) non-addictive, non-dependence-producing pharmacology, and (5) intranasal delivery that is simple and needle-free. Its limitations are (1) thin Western evidence base, (2) variable quality from research chemical suppliers, (3) lack of FDA regulation or oversight, (4) modest effect magnitude in some users relative to expectations, and (5) cost relative to generic anxiety pharmacology. This entry covers the pharmacology, clinical evidence, practical use considerations, and honest framing of the evidence gaps. Cross-reference with Semax, DSIP, and Epithalon for a complete picture of the Russian research peptide landscape.", "url": "https://www.bodyhackguide.co/compound/selank", "image": "https://www.bodyhackguide.co/og-image.png", "brand": { "@type": "Brand", "name": "Research Compound" }, "offers": { "@type": "AggregateOffer", "lowPrice": "25.00", "highPrice": "89.99", "priceCurrency": "USD", "offerCount": "6", "availability": "https://schema.org/InStock", "offers": [ { "@type": "Offer", "price": "25.00", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "itemCondition": "https://schema.org/NewCondition", "url": "https://ionpeptide.com/product/selank-2/?ref=reddit15", "seller": { "@type": "Organization", "name": "Ion Peptide", "url": "https://ionpeptide.com" }, "name": "Selank 5mg vial" }, { "@type": "Offer", "price": "34.65", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "itemCondition": "https://schema.org/NewCondition", "url": "https://ionpeptide.com/product/selank-2/?ref=reddit15", "seller": { "@type": "Organization", "name": "Ion Peptide", "url": "https://ionpeptide.com" }, "name": "Selank 10mg vial" }, { "@type": "Offer", "price": "39.99", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "itemCondition": "https://schema.org/NewCondition", "url": "https://optimumformula.co/product/selank/?ref=ruyhjwqh", "seller": { "@type": "Organization", "name": "Optimum Formula", "url": "https://optimumformula.co" }, "name": "Selank 10mg vial" }, { "@type": "Offer", "price": "39.99", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "itemCondition": "https://schema.org/NewCondition", "url": "https://researchchemhq.co/product/selank-10mg/?ref=oyxnywoz", "seller": { "@type": "Organization", "name": "ResearchChemHQ", "url": "https://researchchemhq.co/?ref=oyxnywoz" }, "name": "Selank 10mg vial" }, { "@type": "Offer", "price": "44.99", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "itemCondition": "https://schema.org/NewCondition", "url": "https://www.vandl-labs.com/product/selank-2/?ref=choncho", "seller": { "@type": "Organization", "name": "VANDL Labs", "url": "https://www.vandl-labs.com/?ref=choncho" } }, { "@type": "Offer", "price": "89.99", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "itemCondition": "https://schema.org/NewCondition", "url": "https://bhglabs.co/product/selank/?ref=zmgqyxku", "seller": { "@type": "Organization", "name": "BHG Labs", "url": "https://bhglabs.co/?ref=zmgqyxku" } } ] } }, { "@context": "https://schema.org", "@type": "MedicalWebPage", "name": "Selank", "description": "Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro, 750 Da molecular weight) developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences as a synthetic analog of tuftsin — an immunomodulatory tetrapeptide (Thr-Lys-Pro-Arg) that is naturally cleaved from the Fc region of immunoglobulin G. The original tuftsin molecule has well-documented immunomodulatory and neurotropic effects but is rapidly degraded by peptidases in plasma, limiting its therapeutic utility. Selank adds a Pro-Gly-Pro tail to the tuftsin sequence, which confers resistance to enzymatic degradation while preserving pharmacological activity. In Russia, Selank has been approved since 2004 for the treatment of generalized anxiety disorder (GAD) and is available by prescription at pharmacies across the Russian Federation and several neighboring countries. It is marketed as a 0.15% intranasal solution under the brand name \"Selank\" (╨í╨╡╨╗╨░╨╜╨║) by Peptogen, a Moscow-based pharmaceutical company. In Western markets, Selank has never been submitted for FDA, EMA, or other major regulatory approval — not because of unfavorable data, but because the commercial pharmaceutical industry has no mechanism to profit from a peptide with an expired patent and no Western development sponsor. As a result, Selank circulates in the biohacking and peptide-curious community primarily as a \"research chemical\" through specialty peptide suppliers, where it is sold in intranasal spray or injectable formulations. The pharmacological profile of Selank is distinctive among anxiolytics. Unlike benzodiazepines, it does NOT cause sedation, cognitive dulling, tolerance, dependence, or withdrawal. Unlike SSRIs, it has rapid onset (within 30-60 minutes of intranasal administration) and effects that outlast plasma presence. Unlike buspirone, it does not require weeks of chronic dosing to manifest effects. The compound appears to work through modulation of multiple neurotransmitter systems simultaneously — GABAergic, serotonergic, dopaminergic, and endogenous opioid — producing what the Russian clinical literature describes as an \"anxiolytic + nootropic\" profile: the user feels calmer but also more mentally engaged, not sedated. This unusual combination has driven substantial interest in Western biohacking circles as an alternative or adjunct to conventional anxiety pharmacology. Selank has been studied in Russian clinical populations for over two decades with a consistent efficacy and safety pattern across roughly 30-50 published clinical papers. The evidence base is real but has important limitations: most trials are Russian-language, published in Russian journals, with small sample sizes (often 30-100 patients), and use Russian psychiatric rating scales rather than the validated Western instruments (GAD-7, HAM-A, Beck Anxiety Inventory) that would facilitate cross-validation. Western meta-analyses and systematic reviews are essentially nonexistent. The Russian regulatory approval is real and meaningful — Russian drug regulation, while different from FDA standards, does require efficacy and safety evidence — but it does not automatically translate to confidence in Western evidence-based medicine frameworks. For the biohacking community, Selank's appeal is the combination of (1) rapid-acting anxiolysis without sedation, (2) cognitive enhancement rather than dulling, (3) favorable safety profile across decades of Russian use, (4) non-addictive, non-dependence-producing pharmacology, and (5) intranasal delivery that is simple and needle-free. Its limitations are (1) thin Western evidence base, (2) variable quality from research chemical suppliers, (3) lack of FDA regulation or oversight, (4) modest effect magnitude in some users relative to expectations, and (5) cost relative to generic anxiety pharmacology. This entry covers the pharmacology, clinical evidence, practical use considerations, and honest framing of the evidence gaps. Cross-reference with Semax, DSIP, and Epithalon for a complete picture of the Russian research peptide landscape.", "lastReviewed": "2026-05-04T11:34:38.257+00:00", "url": "https://www.bodyhackguide.co/compound/selank", "author": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "reviewedBy": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "publisher": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" }, "mainContentOfPage": { "@type": "WebPageElement", "cssSelector": "main" }, "about": { "@type": "Drug", "name": "Selank", "alternateName": [ "TP-7", "Selank Spray" ], "description": "Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro, 750 Da molecular weight) developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences as a synthetic analog of tuftsin — an immunomodulatory tetrapeptide (Thr-Lys-Pro-Arg) that is naturally cleaved from the Fc region of immunoglobulin G. The original tuftsin molecule has well-documented immunomodulatory and neurotropic effects but is rapidly degraded by peptidases in plasma, limiting its therapeutic utility. Selank adds a Pro-Gly-Pro tail to the tuftsin sequence, which confers resistance to enzymatic degradation while preserving pharmacological activity. In Russia, Selank has been approved since 2004 for the treatment of generalized anxiety disorder (GAD) and is available by prescription at pharmacies across the Russian Federation and several neighboring countries. It is marketed as a 0.15% intranasal solution under the brand name \"Selank\" (╨í╨╡╨╗╨░╨╜╨║) by Peptogen, a Moscow-based pharmaceutical company. In Western markets, Selank has never been submitted for FDA, EMA, or other major regulatory approval — not because of unfavorable data, but because the commercial pharmaceutical industry has no mechanism to profit from a peptide with an expired patent and no Western development sponsor. As a result, Selank circulates in the biohacking and peptide-curious community primarily as a \"research chemical\" through specialty peptide suppliers, where it is sold in intranasal spray or injectable formulations. The pharmacological profile of Selank is distinctive among anxiolytics. Unlike benzodiazepines, it does NOT cause sedation, cognitive dulling, tolerance, dependence, or withdrawal. Unlike SSRIs, it has rapid onset (within 30-60 minutes of intranasal administration) and effects that outlast plasma presence. Unlike buspirone, it does not require weeks of chronic dosing to manifest effects. The compound appears to work through modulation of multiple neurotransmitter systems simultaneously — GABAergic, serotonergic, dopaminergic, and endogenous opioid — producing what the Russian clinical literature describes as an \"anxiolytic + nootropic\" profile: the user feels calmer but also more mentally engaged, not sedated. This unusual combination has driven substantial interest in Western biohacking circles as an alternative or adjunct to conventional anxiety pharmacology. Selank has been studied in Russian clinical populations for over two decades with a consistent efficacy and safety pattern across roughly 30-50 published clinical papers. The evidence base is real but has important limitations: most trials are Russian-language, published in Russian journals, with small sample sizes (often 30-100 patients), and use Russian psychiatric rating scales rather than the validated Western instruments (GAD-7, HAM-A, Beck Anxiety Inventory) that would facilitate cross-validation. Western meta-analyses and systematic reviews are essentially nonexistent. The Russian regulatory approval is real and meaningful — Russian drug regulation, while different from FDA standards, does require efficacy and safety evidence — but it does not automatically translate to confidence in Western evidence-based medicine frameworks. For the biohacking community, Selank's appeal is the combination of (1) rapid-acting anxiolysis without sedation, (2) cognitive enhancement rather than dulling, (3) favorable safety profile across decades of Russian use, (4) non-addictive, non-dependence-producing pharmacology, and (5) intranasal delivery that is simple and needle-free. Its limitations are (1) thin Western evidence base, (2) variable quality from research chemical suppliers, (3) lack of FDA regulation or oversight, (4) modest effect magnitude in some users relative to expectations, and (5) cost relative to generic anxiety pharmacology. This entry covers the pharmacology, clinical evidence, practical use considerations, and honest framing of the evidence gaps. Cross-reference with Semax, DSIP, and Epithalon for a complete picture of the Russian research peptide landscape.", "activeIngredient": "Selank", "administrationRoute": "Intranasal", "mechanismOfAction": "Primary Mechanism: Multi-System Neurochemical Modulation Selank does not have a single clean receptor-binding mechanism. Unlike benzodiazepines (GABA-A positive allosteric modulators), SSRIs (serotonin reuptake inhibition), or buspirone (5-HT1A partial agonism), Selank produces its anxiolytic and nootropic effects through coordinated modulation of multiple neurotransmitter systems. The most consistently documented mechanisms include: GABAergic Modulation Selank increases GABAergic tone in several brain regions, particularly the hypothalamus and limbic structures. Unlike benzodiazepines, this increase does NOT appear to be through direct GABA-A receptor binding. Instead, Selank appears to: Increase GABA release from presynaptic terminals Modulate GABA-A receptor subunit expression over time Enhance GABAergic signaling indirectly through kinase cascades This GABAergic enhancement contributes to the anxiolytic effect but does so without producing the sedation, muscle relaxation, and cognitive dulling that benzodiazepines cause ([Kozlovskaya et al., 2003]). Serotonergic Effects Selank modulates serotonin metabolism, increasing brain serotonin turnover and affecting tryptophan uptake. Effects on specific 5-HT receptors are less well-characterized, but the compound appears to interact indirectly with serotonergic systems in a way that contributes to mood stabilization without the acute side effect burden of SSRIs ([Samotrueva et al., 2011]). Endogenous Opioid System Selank potentiates activity of endogenous opioid systems, particularly enkephalin-dependent pathways. This is thought to contribute to the mood-elevating effect and may explain the subjective sense of well-being that many users report. Unlike exogenous opioids, this potentiation does NOT produce dependence, tolerance, or respiratory depression. The effect appears to be modulation of enkephalinase enzymes (reducing enkephalin breakdown) rather than direct opioid receptor agonism. BDNF and Neurotrophic Effects Selank increases expression of brain-derived neurotrophic factor (BDNF), a key neurotrophin involved in synaptic plasticity, learning, memory, and adult neurogenesis. Elevated BDNF is a common downstream mechanism of antidepressants, exercise, and other pro-cognitive interventions. Selank's nootropic effects — improved concentration, memory, and cognitive endurance — are thought to partially derive from BDNF elevation over chronic dosing ([Inozemtseva et al., 2008]). Immunomodulatory Effects Selank inherits some immunomodulatory activity from its tuftsin parent. It affects cytokine expression, lymphocyte activation, and inflammatory markers in ways that may contribute to mood and cognitive effects through gut-brain axis and neuroinflammation pathways. This is less clinically relevant than the direct neuropharmacological effects but may contribute to long-term benefit. Gene Expression and Epigenetic Effects Emerging research suggests Selank modulates expression of genes involved in anxiety, depression, and memory circuits. The full scope of these effects is not well-characterized, but it contributes to the \"long-tail\" of clinical benefit that appears to outlast immediate plasma exposure. Absence of Classical Receptor Binding Extensive screening has not identified a single high-affinity receptor for Selank. Unlike most pharmacologically active peptides (oxytocin, vasopressin, opioids, angiotensin, etc.), Selank does not bind with high affinity to any known peptide receptor. This is unusual and has led researchers to propose that Selank: Activates multiple lower-affinity sites in parallel Modulates enzymatic activity (peptidases, kinases) rather than directly signaling through receptors Affects membrane properties or intracellular signaling in non-classical ways Binds to a receptor that remains uncharacterized Whatever the molecular explanation, the clinical pharmacology is the empirical fact: intranasal Selank 300 mcg produces measurable anxiolytic and nootropic effects in humans that show up on psychiatric rating scales and in EEG measurements. Pharmacokinetics Selank is administered intranasally as a 0.15% aqueous solution (1.5 mg/mL). Each 0.05 mL (50 mcL) spray delivers 75 mcg of Selank; a typical 2-spray dose (one spray per nostril) delivers approximately 150 mcg, and 4 sprays deliver 300 mcg. Key pharmacokinetic features: Rapid onset: Effects begin within 15-30 minutes of intranasal administration Peak effect: 30-60 minutes after dosing Duration of effect: 4-8 hours per dose, though some effects outlast plasma exposure Plasma half-life: Short — the intact peptide is cleared from blood within 1-2 hours Bioavailability: Substantially higher via intranasal than oral route due to bypass of GI peptidases CNS penetration: Intranasal delivery provides direct access via olfactory and trigeminal nerve pathways, bypassing the blood-brain barrier Metabolism: Enzymatic cleavage to smaller peptide fragments; some fragments may retain activity Accumulation: Does not accumulate with chronic dosing Intranasal vs. Other Routes Intranasal (standard): Optimal for CNS-targeted effects. Direct nose-to-brain delivery via olfactory pathway is the primary reason intranasal works well for neuropeptides. Subcutaneous injection: Used in some research protocols and by some biohackers. May produce somewhat different profile emphasizing peripheral effects (immunomodulation, HPA axis). Not commonly used for anxiolytic indication. Intramuscular injection: Used in research; not practical for home use. Oral: Essentially ineffective due to GI peptidase degradation of peptide. Sublingual: Limited data; may provide partial absorption but less characterized than intranasal. Chronic Dosing Effects Chronic Selank administration (weeks to months) appears to produce progressive benefits beyond acute effects: BDNF elevation that accumulates over weeks Gene expression changes affecting anxiety-related pathways Potential \"trait\" anxiolysis with diminishing acute effect over time but maintained baseline benefit No evidence of tachyphylaxis at therapeutic doses This chronic effect pattern means Selank's full clinical value may only emerge over 4-8+ weeks of regular use, similar to SSRIs but without the initial activation/sedation side effects.", "dosageForm": "vial, nasal", "legalStatus": "Not approved for human use (research chemical)", "warning": "For research purposes only. Not for human consumption." } }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What is Selank and where is it from?", "acceptedAnswer": { "@type": "Answer", "text": "Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It's a stabilized synthetic analog of tuftsin, a naturally-occurring immunomodulatory peptide. Selank has been approved as a prescription anxiolytic in Russia since the 2000s under the brand name Selank, manufactured by Peptogen. In Western markets, it is sold as a 'research chemical' through peptide suppliers because no Western pharmaceutical company has pursued FDA approval." } }, { "@type": "Question", "name": "Is Selank approved by the FDA?", "acceptedAnswer": { "@type": "Answer", "text": "No. Selank is approved by the Russian Federation state drug regulatory agency (Roszdravnadzor) for generalized anxiety disorder, but has never been submitted for FDA approval. This is primarily a commercial decision - the molecule is off-patent and no Western company has sufficient financial incentive to pursue development. The evidence base exists in Russian clinical literature but not in the large Western-standard trials that FDA requires. Selank circulates in the US exclusively through research peptide suppliers." } }, { "@type": "Question", "name": "How does Selank compare to benzodiazepines?", "acceptedAnswer": { "@type": "Answer", "text": "Selank produces anxiolytic effects comparable to benzodiazepines in Russian comparative trials (Zozulya et al., 2008) but with a dramatically different profile: NO sedation, NO cognitive impairment, NO dependence, NO tolerance, NO withdrawal. Selank users maintain or improve cognitive performance while anxious symptoms reduce. Benzodiazepines cause sedation, memory problems, and create dependence within weeks to months. For mild-to-moderate chronic anxiety, Selank's profile is clearly favorable; for severe acute anxiety or panic, benzodiazepines' rapid and strong effect may still be preferred." } }, { "@type": "Question", "name": "How should I dose Selank for anxiety?", "acceptedAnswer": { "@type": "Answer", "text": "Standard starting dose is 150 mcg (1 spray each nostril) morning for first week, then increase to 300 mcg (2 sprays each nostril) morning. For ongoing anxiety, consider adding afternoon dose of 150-300 mcg. Total daily dose typically 300-600 mcg; Russian therapeutic protocols use up to 900 mcg daily divided into 2-3 doses. For acute situational anxiety (public speaking, medical appointments), 150-300 mcg 30-60 minutes before the event. Take 2-4 week courses with 1-2 week breaks. This is research/educational information, not medical advice." } }, { "@type": "Question", "name": "How quickly does Selank work?", "acceptedAnswer": { "@type": "Answer", "text": "Acute anxiolytic effects begin within 15-30 minutes of intranasal administration, peak at 30-60 minutes, and last 4-8 hours per dose. Chronic effects (BDNF elevation, gene expression changes) accumulate over weeks of regular use, producing sustained 'trait' improvements in anxiety baseline over 2-8 weeks. This fast-onset + chronic-accumulation profile distinguishes Selank from SSRIs (slow onset, purely chronic) and benzodiazepines (fast onset, purely acute)." } }, { "@type": "Question", "name": "Can Selank be used with antidepressants?", "acceptedAnswer": { "@type": "Answer", "text": "Formal interaction data are limited, but Selank has no documented dangerous interaction with SSRIs (sertraline, escitalopram, fluoxetine, etc.) or SNRIs (venlafaxine, duloxetine), and it is commonly combined in Russian practice. It may be useful as a rapid-acting adjunct during the 2-4 week SSRI onset period or for residual anxiety on stable SSRI therapy. A theoretical serotonin-syndrome concern exists only at very high combined doses; at standard dosing this is not a clinical issue. Consult your prescribing clinician, especially if taking multiple psychiatric medications." } }, { "@type": "Question", "name": "What are Selank's side effects?", "acceptedAnswer": { "@type": "Answer", "text": "Selank has one of the best safety profiles in the anxiolytic space. Common: mild nasal irritation (10-15%), mild headache (5-10%), altered taste during administration. Uncommon: dizziness, mild fatigue, nausea. NOT reported: dependence, tolerance, withdrawal, cognitive impairment, sexual dysfunction, weight gain, emotional blunting. Over years of Russian clinical use, no serious adverse events have been reported at therapeutic doses. This favorable profile is one of the main reasons for Selank's popularity in biohacking communities, though rigorous Western safety data are lacking." } }, { "@type": "Question", "name": "Is Selank addictive?", "acceptedAnswer": { "@type": "Answer", "text": "No. Selank has NO documented addiction liability. Russian pharmacovigilance over many years of clinical use has not identified dependence, tolerance, withdrawal syndromes, or abuse patterns. This fundamentally distinguishes Selank from benzodiazepines, opioids, alcohol, and other anxiolytics that produce dependence. Selank can be stopped abruptly without medical supervision and restarted as needed without dose escalation. This profile makes it particularly appealing to users concerned about dependence with conventional anxiolytics." } }, { "@type": "Question", "name": "Does Selank work for cognitive enhancement?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, modestly. Selank produces cognitive improvements beyond what anxiolysis alone explains (Medvedev et al., 2014), reported as mild nootropic effects on attention and memory. The mechanism appears to involve BDNF elevation, gene expression effects, and multi-neurotransmitter modulation. However, cognitive effects are modest - not dramatic. Selank is better characterized as 'cognition-preserving + mild enhancement' than a strong nootropic. For stronger cognitive effects, it's often stacked with Semax, which has more direct nootropic activity." } }, { "@type": "Question", "name": "What's the difference between Selank and Semax?", "acceptedAnswer": { "@type": "Answer", "text": "Both are Russian intranasal peptides with overlapping but distinct profiles. Semax is primarily a nootropic (cognition, focus, alertness) derived from ACTH, acting strongly on BDNF, dopamine, and neurotrophic systems. Selank is primarily anxiolytic (calm, stress tolerance) derived from tuftsin, acting on GABA, serotonin, and opioid systems. Semax makes you more alert and focused; Selank makes you calmer without sedation. Combined, they produce 'calm focus' and are frequently stacked: Semax morning for cognitive activation, Selank PRN or standing for anxiety management. Both have similar safety profiles and Russian regulatory approval." } } ] }, { "@context": "https://schema.org", "@type": "Organization", "@id": "https://www.bodyhackguide.co#organization", "name": "BodyHackGuide", "alternateName": "BHG", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/logo.png", "width": 512, "height": 512 }, "description": "Evidence-based research reference for peptides and nootropics. 124+ compound profiles, interactive dosing calculators, vendor price comparisons, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. We earn a commission on purchases through some of our links.", "foundingDate": "2024", "founder": { "@id": "https://www.bodyhackguide.co/about#person" }, "sameAs": [ "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher", "https://discord.gg/Mhq5UdRYBA" ], "knowsAbout": [ "Peptide research", "Nootropic research", "Biohacking", "Compound dosing", "Vendor transparency" ], "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards", "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards", "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards" } ] ```